mecamylamine has been researched along with Injury, Myocardial Reperfusion in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvillo, L | 1 |
| Vanoli, E | 1 |
| Andreoli, E | 1 |
| Besana, A | 1 |
| Omodeo, E | 1 |
| Gnecchi, M | 1 |
| Zerbi, P | 1 |
| Vago, G | 1 |
| Busca, G | 1 |
| Schwartz, PJ | 1 |
1 other study available for mecamylamine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Apoptosis; Cardiac Pacing, Artificial; Chemokine C | 2011 |